Cargando…
BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression
Bactericidal/permeability-increasing-fold-containing family B member 1 (BPIFB1, previously named LPLUNC1) is highly expressed in the nasopharynx and significantly downregulated in nasopharyngeal carcinoma (NPC). Low expression is also associated with poor prognosis in patients with NPC. Radiotherapy...
Autores principales: | Wei, Fang, Tang, Le, He, Yi, Wu, Yingfen, Shi, Lei, Xiong, Fang, Gong, Zhaojian, Guo, Can, Li, Xiayu, Liao, Qianjin, Zhang, Wenling, Ni, Qianxi, Luo, Jia, Li, Xiaoling, Li, Yong, Peng, Cong, Chen, Xiang, Li, Guiyuan, Xiong, Wei, Zeng, Zhaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864881/ https://www.ncbi.nlm.nih.gov/pubmed/29568064 http://dx.doi.org/10.1038/s41419-018-0409-0 |
Ejemplares similares
-
BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM
por: Wei, Fang, et al.
Publicado: (2018) -
HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis
por: Zhou, Yujuan, et al.
Publicado: (2016) -
LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways
por: Yang, Yixin, et al.
Publicado: (2013) -
Correction: LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways
por: Yang, Yixin, et al.
Publicado: (2013) -
BPIFB1 (LPLUNC1) is upregulated in cystic fibrosis lung disease
por: Bingle, Lynne, et al.
Publicado: (2012)